Table 3.
Effects of Interventions for trials.
| Compadretti et al., 2006 | Non-randomized controlled clinical trial |
||
|---|---|---|---|
| Cephalometric measurements (mm) | T1 (3 months) | T2 (≥12 months) | Mean – SD |
| Nasal cavity width | Not reported | Not reported | 2.2 ± 2.1 |
| Intercanine distance | Not reported | Not reported | Not reported |
| Intermolar distance | Not reported | Not reported | 4.8 ± 10.6 |
| Interzygomatic distance | Not reported | Not reported | 7.0 ± 8.6 |
| Cappellette Jr, et al., 2017 | Non-randomized controlled clinical trial |
|||
|---|---|---|---|---|
| Control Group |
Experimental Group |
|||
| Dolphin measurements (mm3) | T0 (pre-RME) Mean – SD | T1 (3 months) Mean – SD | T0 (pre-RME) Mean – SD | T1 (3 months) Mean – SD |
| Nasal volume | 34,426.0 ± 5,059.0 | 34,488.7 ± 5,088.9 | 33,418.7 ± 6,107.6 | 38,450.6 ± 6,329.1 |
| Oropharyngeal volume | 7,531.0 ± 1,535.0 | 7,572.4 ± 1,526.4 | 10,262.3 ± 2,421.1 | 12,955.1 ± 2,942.8 |
| Izuka et al., 2015 | Non-randomized uncontrolled clinical trial |
|
|---|---|---|
| Cephalometric measurements (mm) | T0 (pre-RME) Mean – SD | T1 (3 months) Mean – SD |
| Nasal cavity width | Not reported | Not reported |
| Intercanine distance | 16.3 ± 1.7 | 19.1 ± 1.8 |
| Intermolar distance | 22.6 ± 2.5 | 25.4 ± 3.0 |
| Interzygomatic distance | Not reported | Not reported |
| Dolphin measurements (mm3) | T0 (pre-RME) Mean – SD | T1 (3 months) Mean – SD |
| Nasal volume | 6114.4 ± 3490.4 | 7760.5 ± 3841.4 |
| Oropharyngeal volume | 6378.2 ± 2357.5 | 7826.8 ± 4109.9 |
| Matsumoto et al., 2016 | |||
|---|---|---|---|
| Cephalometric measurements (mm) | T0 (pre-RME) Mean – SD | T1 (3 months) Mean – SD | T2 (≥12 months) Mean – SD |
| Nasal cavity width | 24.25 ± 2.08 | 25.69 ± 2.22 | 27.98 ± 2.68 |
| Intercanine distance | Not reported | Not reported | Not reported |
| Intermolar distance | Not reported | Not reported | Not reported |
| Interzygomatic distance | 58.88 ± 2.80 | 62.12 ± 2.70 | 66.29 ± 3.53 |